What Kaiser Permanente Ventures does

Kaiser Permanente Ventures (KPV) is the corporate venture capital arm of Kaiser Permanente, one of the largest integrated healthcare delivery systems in the United States. Founded in 1998 and co-founded by Chris Grant (now COO and EVP of The Permanente Federation), KPV invests in promising healthcare companies across Health Information Technology, Digital Health, Healthcare Services, Medical Devices, and Diagnostics & Precision Medicine. Over 25 years, the firm has executed more than 70 investments and deployed over $700 million in capital, building a portfolio that includes Abridge (generative AI for clinical documentation), Arine (AI medication optimization), Garner Health (provider quality analytics, valued at $2.74B at Series E), DexCare (patient demand platform), Freenome (multiomics cancer detection), Kate Farms (plant-based clinical nutrition), NOCD/Noto (behavioral health), Omada Health (virtual chronic care, IPO'd June 2025), and Vesta Healthcare (home-based virtual care).

The firm's core technology is its investment platform itself—a curated pipeline that leverages Kaiser Permanente's $93-101 billion integrated delivery network (24,605+ clinicians, 40 acute care hospitals, 618+ facilities, and 12.6 million members) as both a deal sourcing engine and a clinical validation asset. KPV does not develop products, sell services to external customers, or operate software platforms; it deploys equity capital into healthcare startups from early to growth stages. The firm is headquartered at 1 Kaiser Plaza, 22nd Floor, Oakland, CA, with a core team of approximately 7-8 investment professionals led by Managing Directors Amy Belt Raimundo and Daniel van den Bergh.

KPV's business model is that of a strategic corporate venture fund rather than an external AUM-gathering manager. Returns are generated through venture capital rates of return on equity investments, supplemented by the strategic value of piloting portfolio innovations inside the Kaiser Permanente system. Capital is sourced from the parent organization and is not externally raised, meaning KPV balances financial returns with strategic alignment to Kaiser Permanente's healthcare delivery mission. Distribution occurs through direct equity participation in priced funding rounds alongside tier-1 venture capital firms and peer strategic CVCs, with go-to-market executed via deep engagement with Kaiser Permanente operators and clinical leaders to identify pressing unmet needs.

Name

Kaiser Permanente Ventures

Legal name

Kaiser Permanente Ventures

Website

http://www.kpventures.com

Company type

Private

Founded year

1945

Operating status

Operating

Headcount range

11–50 employees

Short description

Kaiser Permanente Ventures is the corporate venture capital arm of Kaiser Permanente, investing equity in early- to growth-stage healthcare companies across digital health, medical devices, diagnostics, and healthcare services. The firm leverages its parent's integrated delivery network to source deals and validate portfolio innovations.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Other Investment Pools and Funds (5259)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Healthcare venture capital
• Strategic investments
• Corporate venture capital
• Healthcare innovation funding
• Medical technology investing

Headquarters

HQ city

Oakland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Venture Capital Returns: Strategic venture investing that generates venture capital rates of return while supporting Kaiser Permanente's healthcare mission. Invests in promising healthcare companies targeting areas of real need.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Kaiser Permanente Ventures is the corporate venture capital arm of Kaiser Permanente that invests equity capital in promising healthcare companies spanning Health Information Technology, Digital Health, Healthcare Services, Medical Devices, and Diagnostics & Precision Medicine. The firm deploys capital from seed to growth stages and supports portfolio companies with strategic partnership opportunities, market validation, and access to Kaiser Permanente's clinical expertise and delivery network. It has made over 70 investments deploying more than $700 million in capital since 1998.

Product overview

Kaiser Permanente Ventures (KPV) is a corporate venture capital firm, not a product company. KPV was founded over 25 years ago and has invested in over 67 companies, targeting areas including Health Information Technology (Enterprise Solutions), Digital Health, Healthcare Services, Medical Devices, and Diagnostics and Precision Medicine. The firm leverages Kaiser Permanente's $93B integrated delivery system assets and capabilities to support innovative healthcare companies. KPV does not develop, sell, or distribute its own products or services to external customers. Notable portfolio companies include Abridge (generative AI for clinical documentation), Ordr (IoT security), DexCare (patient demand platform), NOCD (OCD treatment), Freenome (multiomics blood testing for early cancer detection), and Garner Health (provider quality analytics).

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Kaiser PermanenteflagshipStrategic or Co-development PartnerKaiser Permanente Ventures operates in deep partnership with Kaiser Permanente, leveraging insights from 24,605+ clinicians, 40 hospitals, and 618+ healthcare facilities to identify and support innovative healthcare companies.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cigna Ventures: Cigna Group's CVC focused on healthcare innovation; co-invested with KPV in NOCD. Directly comparable as a healthcare-focused strategic CVC investing from a payer/insurer parent.
• Optum Ventures (UnitedHealth Group): Optum Ventures is UnitedHealth Group's CVC arm, investing across healthcare AI, digital health, and care delivery. Most directly comparable peer given similar integrated-payer-provider parent backing and broad healthcare mandate.
• CVS Health Ventures: CVS Health's CVC arm investing in digital health and healthcare services; co-invested with KPV in Abridge. Highly comparable peer with overlapping healthcare thesis and similar strategic-investor model.
• Mayo Clinic Ventures: Mayo Clinic's CVC focused on medical devices, diagnostics, and digital health; co-invested with KPV in Ordr. Comparable as a leading integrated delivery system's CVC with clinical validation moats.
• UPMC Enterprises: UPMC's venture arm investing in healthcare innovation from a large integrated delivery system parent. Comparable peer structure: IDS-backed CVC with clinical validation access for portfolio companies.
• Providence Ventures: Providence Health's CVC; co-invested with KPV in DexCare. Direct peer as another IDS-backed healthcare CVC with similar stage range and thesis.
• Mass General Brigham AIDIF: Mass General Brigham's venture/innovation fund; co-invested with KPV in Abridge and DexCare. Direct peer as another major academic health system CVC with similar investment profile.

Emerging players

• 7wireVentures: Independent digital health-focused VC that co-led NOCD rounds with KPV. Comparable as a healthcare-specialized investor with overlapping thesis in consumer health and care navigation.
• Define Ventures: Healthcare-focused VC firm co-investing with KPV in DexCare rounds. Comparable as a sector-specialized VC with overlapping digital health thesis and co-investment relationship.
• Frist Cressey Ventures: Healthcare-focused VC co-investing with KPV in DexCare rounds. Comparable as a healthcare-specialized investor with overlapping digital health and care delivery thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/KPShare
• Facebookfacebook.com/kpthrive
• LinkedInlinkedin.com/company/1550

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments140 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kaiser Permanente Ventures